Application of Extended Reality (XR)-Assisted CT-Guided Localization of Pulmonary Nodules in Thoracoscopic Sublobar Resection.

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · May 13, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new approach to help doctors locate small lung nodules during surgery using advanced technology called Extended Reality (XR). The goal is to see if XR can improve the precision of locating these nodules, which are small growths in the lung that may indicate cancer. The study is not yet recruiting participants, but it plans to include adults between the ages of 18 and 80 who are scheduled for surgery to remove lung nodules smaller than 2 centimeters, specifically those located in the outer part of the lung.

If you or a family member are considering this trial, you would need to meet certain criteria, such as being within the specified age range and having a suitable lung nodule. Participants will likely experience a combination of traditional imaging techniques and XR technology, which may enhance the surgical process. It's also important to note that individuals needing a larger lung surgery (lobectomy) or those who haven't given consent are not eligible for this trial. This innovative approach aims to improve surgical outcomes and make the procedure safer for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged between 18 and 80 who are scheduled to undergo lung nodule resection surgery.
• • Patients with lung nodules smaller than 2 cm that require preoperative localization.
• • Patients with lung nodules located in the outer one-third of the lung.
• Exclusion Criteria:
• • Patients younger than 18 or older than 80 years.
• • Patients requiring lobectomy.
• • Patients who have not provided written informed consent.
• • Vulnerable populations.